Larvol Delta - vTv-Therapeutics-Announces-Results-of-Multiple-Ascending-Dose-Study-and-Development-Plan-for-HPP737-an-Oral-PDE4-Inhibitor-for-the-Treatment-of-Psoriasis

HPP737 - vTv Therapeutics

https://www.globenewswire.com/news-release/2021/09/23/2302624/0/en/vTv-Therapeutics-Announces-Results-of-Multiple-Ascending-Dose-Study-and-Development-Plan-for-HPP737-an-Oral-PDE4-Inhibitor-for-the-Treatment-of-Psoriasis.html

Sep 23, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next